X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3) 3
index medicus (3) 3
adult (2) 2
antineoplastic agents - therapeutic use (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
care and treatment (2) 2
cytotoxicity (2) 2
drug resistance, neoplasm (2) 2
female (2) 2
hematology (2) 2
lymphoma, non-hodgkin - drug therapy (2) 2
lymphomas (2) 2
male (2) 2
middle aged (2) 2
recurrence (2) 2
treatment outcome (2) 2
acute lymphoblastic-leukemia (1) 1
adolescent (1) 1
alcl (1) 1
alk (1) 1
allogeneic stem cell transplants (1) 1
antibody-drug conjugates (1) 1
antigens, cd34 (1) 1
antigens, neoplasm (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
antineoplastic agents - administration & dosage (1) 1
antineoplastic agents - pharmacology (1) 1
apoptosis (1) 1
boost (1) 1
brentuximab vedotin (1) 1
cancer (1) 1
cd30 (1) 1
cd30-positive hematologic malignancies (1) 1
cd34 (1) 1
cell cycle (1) 1
cell division (1) 1
chemotherapy (1) 1
clinical neurology (1) 1
clinical trials as topic (1) 1
consensus recommendations (1) 1
consolidation chemotherapy (1) 1
crizotinib (1) 1
cutaneous t-cell lymphoma (1) 1
development and progression (1) 1
diffuse large b-cell lymphoma (1) 1
disease (1) 1
disease-free survival (1) 1
diseases of the blood and blood-forming organs (1) 1
dosage and administration (1) 1
drug administration schedule (1) 1
enzymes (1) 1
failure (1) 1
follow-up studies (1) 1
gene amplification (1) 1
gene mutations (1) 1
genetic aspects (1) 1
graft survival - physiology (1) 1
graft vs host disease - prevention & control (1) 1
granulocyte colony-stimulating factor (1) 1
growth factors (1) 1
gvhd (1) 1
health aspects (1) 1
hematology, oncology and palliative medicine (1) 1
hematopoietic stem cell transplantation (1) 1
hematopoietic stem cell transplantation - adverse effects (1) 1
hemic and lymphatic diseases (1) 1
hodgkin disease - drug therapy (1) 1
hodgkin lymphoma (1) 1
immunoconjugates - pharmacology (1) 1
immunoconjugates - therapeutic use (1) 1
immunohistochemistry (1) 1
immunology (1) 1
in situ hybridization, fluorescence (1) 1
inhibitor drugs (1) 1
inotuzumab ozogamicin (1) 1
intravenous-infusion (1) 1
kaplan-meier estimate (1) 1
ki-1 antigen - antagonists & inhibitors (1) 1
kinases (1) 1
large-cell lymphoma (1) 1
lung cancer (1) 1
lymphoma - diagnosis (1) 1
lymphoma - drug therapy (1) 1
lymphoma - metabolism (1) 1
lymphoma, non-hodgkin - enzymology (1) 1
macrophage colony stimulating factor (1) 1
methods (1) 1
molecular targeted therapy - methods (1) 1
mutation (1) 1
nervous system (1) 1
neuroblastoma (1) 1
neurosciences (1) 1
non-hodgkin's lymphomas (1) 1
non-peripheral t-cell lymphoma (1) 1
npm (1) 1
objective responses (1) 1
oncology (1) 1
patient outcomes (1) 1
peripheral t-cell (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the National Cancer Institute, ISSN 0027-8874, 2014, Volume 106, Issue 2, pp. djt378 - djt378
Journal Article
Journal Article
Journal of the Peripheral Nervous System, ISSN 1085-9489, 09/2016, Volume 21, Issue 3, pp. 154 - 156
Journal Article
Blood and Lymphatic Cancer: Targets and Therapy, ISSN 1179-9889, 01/2014, Volume 4, Issue default, pp. 69 - 79
Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase protein implicated in a variety of hematological malignancies and solid tumors. ALK contributes... 
Care and treatment | Gene mutations | Protein tyrosine kinase | Physiological aspects | Development and progression | Genetic aspects | Non-Hodgkin's lymphomas | Research | Health aspects | Risk factors | Phosphorylation | Lung cancer | Cell division | Cytotoxicity | Nervous system | Neuroblastoma | Kinases | Proteins | Gene amplification | Cell cycle | Lymphomas | Growth factors | Tumors | Apoptosis
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.